Literature DB >> 2603724

Severe adverse effects of maternal labetalol in a premature infant.

A Haraldsson1, W Geven.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2603724     DOI： 10.1111/j.1651-2227.1989.tb11183.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


× No keyword cloud information.
  4 in total

1.  Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.

Authors:  E B Erdtsieck-Ernste; M G Feenstra; M H Botterblom; J De Barrios; G J Boer
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Half-life of maternal labetalol in a premature infant.

Authors:  A Haraldsson; W Geven
Journal:  Pharm Weekbl Sci       Date:  1989-12-15

3.  Adverse neonatal effects of maternal labetalol treatment.

Authors:  B N Crooks; S A Deshpande; C Hall; M P Platt; D W Milligan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

Review 4.  The Risk for Neonatal Hypoglycemia and Bradycardia after Beta-Blocker Use during Pregnancy or Lactation: A Systematic Review and Meta-Analysis.

Authors:  Rosalie de Bruin; Sarah L van Dalen; Shamaya J Franx; Viraraghavan V Ramaswamy; Sinno H P Simons; Robert B Flint; Gerbrich E van den Bosch
Journal:  Int J Environ Res Public Health       Date:  2022-08-04       Impact factor: 4.614
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.